RPS urges pharmacists to share their pandemic experience with UK Covid-19 Inquiry


Share post:

The Royal Pharmaceutical Society (RPS) has urged pharmacists to share their experience of pandemic to the UK Covid-19 Inquiry, an independent public inquiry set up to examine the impact of the Covid-19 pandemic, and learn lessons for the future.

In order to fully understand the impact of the pandemic on the UK population, the Inquiry is inviting people to share their experiences of the pandemic by launching Every Story Matters – an opportunity for everyone that wishes to, to contribute to the UK Covid-19 Inquiry.

RPS President Professor Claire Anderson said: “You can contribute your experience as a pharmacist or member of the pharmacy team, or in a personal capacity. Pharmacy was on the frontline of the pandemic and I hope many of you will want to contribute your stories. RPS will be contributing as a core participant in the Inquiry, but it’s vital individual voices are heard too.”

Every Story Matters will inform the Inquiry’s work by gathering pandemic experiences which can be brought together and represent the whole of the UK.

The output of Every Story Matters will be a unique, comprehensive account of the UK population’s experiences of the pandemic, to be submitted to the Inquiry’s legal process as evidence.

Every Story Matters aims to provide inclusive methods for people to talk about their experience of the pandemic, so anyone that wants to share their story feels heard, valued, and can contribute to the Inquiry.

Stories will be collated, analysed and turned into themed reports, which will be submitted into each relevant investigation as evidence. The reports will be anonymised.


Please enter your comment!
Please enter your name here

Current Issue June 2023

Related articles

MHRA grants authorisation for LEO Pharma’s Adtralza 2 mL pen solution

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the marketing authorisation of Adtralza, a dermatological solution...

Grundon launches maiden UK-wide inhaler recycling programme

Grundon Waste Management has introduced what it claims to be the UK's first verified nationwide inhaler return and...

‘Record fine imposed on hydrocortisone manufacturers for dominant position abuse and 10,000% price increase’

The Competition Appeal Tribunal (CAT) has upheld the Competition and Markets Authority’s (CMA) findings against two pharmaceutical manufacturers...

Vision Report: Legal reforms, adequate funding imperative for success of community pharmacy

Achieving the community pharmacy vision necessitates legal adjustments and additional funding beyond recent boosts, the pharmacy vision document...